Sharing genomic data accelerates discovery and innovation in cancer research. It enables researchers to identify genetic mutations, understand cancer progression, and develop targeted therapies. Aggregating data from various sources enhances the statistical power of studies, leading to more robust conclusions and faster advancements.
